1. Signaling Pathways
  2. Immunology/Inflammation
  3. Transmembrane Glycoprotein

Transmembrane Glycoprotein

Transmembrane Glycoprotein

Transmembrane glycoproteins are important components of cell membranes and are characterized by oligosaccharide chains covalently linked to polypeptide chains. Glycosylation sites are mainly located in their extracellular regions, achieved by N-linked glycosylation (linked to asparagine residues) or O-linked glycosylation (linked to serine or threonine residues). Sugar chains not only provide structural stability to proteins but also confer functional specificity. Many transmembrane glycoproteins are receptors, such as G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs). Most (clusters of differentiation)CD molecules are also transmembrane glycoproteins expressed on the surface of antigen-presenting cells[1][2].

Transmembrane Glycoprotein Related Products (222):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-E70190
    Tyrosylprotein Sulfotransferase 2
    Activator
    Tyrosylprotein Sulfotransferase 2 (TPST-2) is a subtype of TPST. Tyrosylprotein Sulfotransferase is a 54- to 50-kDa integral membrane glycoprotein of the trans-Golgi network found in essentially all tissues investigated, catalyzing the tyrosine O-sulfation of soluble and membrane proteins passing through this compartment.
    Tyrosylprotein Sulfotransferase 2
  • HY-P991389
    BAT-6005
    Inhibitor
    BAT-6005 is a human monoclonal antibody (mAb) targeting TIGIT. BAT-6005 can be used in Tumor Immunity research.
    BAT-6005
  • HY-P1924A
    IRBP(651-670) human, mouse TFA
    IRBP(651-670) human, mouse (TFA) represents the amino acid sequence from positions 651 to 670 of the interphotoreceptor retinoid binding protein (IRBP). IRBP(651-670) human, mouse (TFA) can be used to induce experimental autoimmune uveitis.
    IRBP(651-670) human, mouse TFA
  • HY-P991305
    AGEN-1571
    AGEN-1571 is a human IgG1 monoclonal antibody (mAb) targeting ILT2. AGEN-1571 promotes adaptive and innate immune responses. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001)
    AGEN-1571
  • HY-P991575
    AT003
    AT003 is a humanized monoclonal antibody targeting EpCAM/TROP1/CD326. AT003 can be used for synthesis of ADC.
    AT003
  • HY-P990235
    Anti-Mouse ICOSL/CD275 (D265A) Antibody (HK5.3)
    Inhibitor
    Anti-Mouse ICOSL/CD275 (D265A) Antibody (HK5.3) is a mouse-derived IgG1 κ type antibody inhibitor, targeting to mouse ICOSL/CD275. Anti-Mouse ICOSL/CD275 (D265A) Antibody (HK5.3) is a chimeric antibody of the original HK5.3 antibody (HY-P990123). Anti-Mouse ICOSL/CD275 (D265A) Antibody (HK5.3) contains the D265A mutation region. Anti-Mouse ICOSL/CD275 (D265A) Antibody (HK5.3) can neutralize ICOSL. Anti-Mouse ICOSL/CD275 (D265A) Antibody (HK5.3) can be used for researches of inflammation and infection.
    Anti-Mouse ICOSL/CD275 (D265A) Antibody (HK5.3)
  • HY-164311
    GPR17 modulator-1
    Modulator
    GPR17 modulator-1 (Compound 2-046) is a modulator for G protein-coupled receptor 17 GPR17, with an IC50<10 nM for hGPR17 in CHO. GPR17 modulator-1 exhibits moderate pharmacokinetic characteristics in mice. GPR17 modulator-1 ix blood-brain barrier (BBB) permeable.
    GPR17 modulator-1
  • HY-P990843
    Anti-Glycophorin A (type M) Antibody (6A7M)
    Anti-Glycophorin A (type M) Antibody (6A7M) is a kind of mouse IgG1, κ chimeric antibody, targeting to human Glycophorin A (type M). The recommend isotype control of Anti-Glycophorin A (type M) Antibody (6A7M): Mouse IgG1 kappa, Isotype Control (HY-P99977).
    Anti-Glycophorin A (type M) Antibody (6A7M)
  • HY-P1822A
    BDC2.5 mimotope 1040-31 TFA
    Inhibitor
    BDC2.5 mimotope 1040-31 TFA, a BDC2.5 TCR reactive peptide, is a strong agonistic peptide for diabetogenic T cell clone BDC2.5, and the 1040-31 peptide is specific for BDC 2.5 TCR Tg+ T cells.
    BDC2.5 mimotope 1040-31 TFA
  • HY-P991470
    Anti-Tenascin C Antibody
    Inhibitor
    Anti-Tenascin C Antibody (Neuradiab antibody) is a human monoclonal antibody (mAb) targeting Tenascin C. Anti-Tenascin C Antibody can be used in Glioblastoma research. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-Tenascin C Antibody
  • HY-P991618
    ST2485
    Inhibitor
    ST2485 is a monoclonal antitenascin antibody. ST2485 shows additivity in tenascin C binding in vitro as well as in a xenograft model. ST2485 binds human tenascin at an epitope partially shared with BC2. ST2485 cross-reacts with murine tenascin. ST2485 can be studied in antitumor research.
    ST2485
  • HY-P990262
    Anti-Mouse CD8 Antibody (HB-129)
    Inhibitor
    Anti-Mouse CD8 Antibody (HB-129) is a mouse-derived IgG2a κ type antibody inhibitor, targeting to mouse CD8. Anti-Mouse CD8 Antibody (HB-129) can deplete CD8+ T cells. Anti-Mouse CD8 Antibody (HB-129) can be used for the researches of cancer, inflammation, immunology and metabolic disease, such as P815 tumor, experimental autoimmune thyroiditis (EAT) and graft versus host disease (GVHD).
    Anti-Mouse CD8 Antibody (HB-129)
  • HY-P991111
    Anti-Mouse TIGIT Antibody (10A7)
    Inhibitor
    Anti-Mouse TIGIT Antibody (10A7) is a mouse IgG2 monoclonal antibody that targets TIGIT. Recommend Isotype Controls: Mouse IgG2a kappa, Isotype Control (HY-P99978).
    Anti-Mouse TIGIT Antibody (10A7)
  • HY-P990852
    Anti-CEACAM7 Antibody (P3-7B)
    Inhibitor
    Anti-CEACAM7 Antibody (P3-7B) is a kind of mouse IgG1, κ chimeric antibody, targeting to human CEACAM7. The recommend isotype control of Anti-CEACAM7 Antibody (P3-7B): Mouse IgG1 kappa, Isotype Control (HY-P99977).
    Anti-CEACAM7 Antibody (P3-7B)
  • HY-P991308
    TRX385
    Antagonist
    TRX385 is a human monoclonal antibody (mAb) targeting LILRB4/ILT3/CD85k. TRX385 can be used in anticancer and antiviral research.
    TRX385
  • HY-P990746
    Lancastotug
    Inhibitor
    Lancastotug is an anti-TIGIT human IgG1 κ monoclonal antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
    Lancastotug
  • HY-170955
    HA-CD44 interaction inhibitor 3
    Inhibitor
    HA-CD44 interaction inhibitor 3 (compound 5d) is a Hyaluronic acid (HY-B0633A) (HA)-CD44 interaction inhibitor with antiproliferative activities. HA-CD44 interaction inhibitor 3 inhibits MDA-MB-231 (CD44++) cells and MCF-7 cells (CD44--) with EC50s of 4.24 μM and 14.74 μM, respectively. HA-CD44 interaction inhibitor 3 shows the potential for cancer research.
    HA-CD44 interaction inhibitor 3
  • HY-P990664
    Anti-Melanotransferrin/CD228 Antibody
    Anti-Melanotransferrin/CD228 Antibody (SC-005 antibody) is a humanized antibody expressed in CHO cells, targeting Melanotransferrin/CD228. Anti-Melanotransferrin/CD228 Antibody carries a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.16 kDa. The isotype control for Anti-Melanotransferrin/CD228 Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-Melanotransferrin/CD228 Antibody
  • HY-P991181
    VTX-1218
    Inhibitor
    VTX-1218 is a humanized IgG1 monoclonal antibody targeting VSIG4.
    VTX-1218
  • HY-P990751
    Nelmastobart
    Inhibitor
    Nelmastobart is an anti-BTN1A1 human IgG4 κ monoclonal antibody. Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
    Nelmastobart